Describing biotech inventions

WASHINGTON - The U.S. Patent and Trademark Office (PTO) issued interim guidelines outlining its requirements for describing a biotechnology invention.

The guidelines are intended to implement Federal Circuit Court decisions that have stipulated that a high degree of specificity is needed in the written descriptions of complex biomolecules, according to a PTO official who asked not to be named...